How to further solidify data on systemic therapy in metastatic renal cell carcinoma (mRCC) in German mRCC registry on the treatment reality.

Goebell, P., Müller, L., Blumenstengel, K., Hübner, A., Lück, A., Koska, M., Marschner, N., 2012.

Eur Urol Suppl 2012;11,e79a DOI:10.1016/S1569-9056(12)60078-5

Studie: TNK; Indikation: Nierenzellkarzinom; Jahr: 2012; Veranstaltung: EAU; Journal: -

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com